GSA Capital Partners’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,647
| Closed | -$432K | – | 1722 |
|
|
2024
Q4 | $432K | Buy |
+36,647
| New | +$432K | 0.03% | 992 |
|
|
2022
Q2 | – | Sell |
-17,260
| Closed | -$275K | – | 1446 |
|
|
2022
Q1 | $275K | Buy |
+17,260
| New | +$275K | 0.04% | 956 |
|
|
2020
Q1 | – | Sell |
-1,916
| Closed | -$314K | – | 1132 |
|
|
2019
Q4 | $314K | Buy |
1,916
+1,391
| +265% | +$228K | 0.04% | 989 |
|
|
2019
Q3 | $77K | Buy |
+525
| New | +$77K | 0.01% | 1295 |
|
|
2018
Q4 | – | Sell |
-570
| Closed | -$129K | – | 1400 |
|
|
2018
Q3 | $129K | Sell |
570
-4,080
| -88% | -$923K | 0.01% | 1534 |
|
|
2018
Q2 | $704K | Buy |
+4,650
| New | +$704K | 0.03% | 960 |
|
|
2018
Q1 | – | Sell |
-2,217
| Closed | -$472K | – | 1635 |
|
|
2017
Q4 | $472K | Sell |
2,217
-1,143
| -34% | -$243K | 0.03% | 967 |
|
|
2017
Q3 | $721K | Buy |
3,360
+1,400
| +71% | +$300K | 0.05% | 726 |
|
|
2017
Q2 | $370K | Buy |
+1,960
| New | +$370K | 0.02% | 1155 |
|